QQ客服 官方微博 反馈留言

	Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
	Yang, Luyu; Dong, Hui; Lu, Huizhi; Liao, Youxia; Zhang, Hao; Xu, Lingwen; Tan, Yun; Cao, Song; Tan, Jinhui; Fu, Shouzhi
刊名	MEDICINE
	2019
卷号	98期号:12
关键词	myocardial infarction prognosis risk stratification YKL-40
ISSN号	0025-7974
DOI	10.1097/MD.0000000000014920
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4234055
专题	武汉大学
推荐引用方式 GB/T 7714	Yang, Luyu,Dong, Hui,Lu, Huizhi,et al. Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. MEDICINE,2019,98(12).
APA	Yang, Luyu.,Dong, Hui.,Lu, Huizhi.,Liao, Youxia.,Zhang, Hao.,...&Fu, Shouzhi.(2019).Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.MEDICINE,98(12).
MLA	Yang, Luyu,et al."Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction".MEDICINE 98.12(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。